Skip to content

Author

Alexander N. Orekhov

We have 4 of 114 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

CELLULAR THERAPIES FOR AUTOIMMUNE RHEUMATIC DISEASES

Autoimmune rheumatic diseases (ARDs) such as systemic lupus erythematosus and rheumatoid arthritis (RA) arise from aberrant immune responses that lead to chronic inflammation and tissue damage. Conventional treatments, including biological disease-modifying antirheumatic drugs (bDMARDs), often provide limited effective...

A. V. Poznyak, V. P. Karagodin, D. Borodko et al. · 0 citations
Review Open access Oct 2026

SIGNALING PATHWAYS: A KEY TO UNLOCKING NEW TREATMENTS FOR SJÖGREN'S SYNDROME

This paper advocates for a multi-target therapeutic approach in SS, aiming to mitigate the intricate cytokine network and restore glandular function, ultimately improving patient outcomes.

A. V. Poznyak, A. Vatlin, D. Borodko et al. · 0 citations
Review Open access Feb 2026

Resveratrol for Atherosclerosis: Potential Mechanisms

as it enhances brain energy metabolism and diminishes oxidative stress. Likewise, another investigation revealed that RV possesses anti-inflammatory and antioxidant characteristics. These properties can help suppress or prevent age-related cardiovascular diseases. Notably, RV has been shown to enhance cardiac contracti...

A. V. Poznyak, S.M. Kozlov, Gulalek A. Babayeva et al. · 0 citations
Review Open access Sep 2026

Mitochondria in Parkinson disease: Genetic and epigenetic components

Advances in understanding mitochondrial biology have enabled the development of novel therapeutic approaches, including activators of the PINK1/Parkin pathway, inhibitors of LRRK2 and α-synuclein aggregation, and strategies promoting mitochondrial biogenesis and intercellular transfer, offering potential for disease mo...

A. V. Poznyak, V. Pavshintsev, Aleksandra O. Utkina et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.